Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment-Reference-Cited by-同舟云学术

Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment

Published:2020-04-15 Issue:5 Volume:37 Page:2288-2302
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Capelli Debora,Saraceni Francesco,Fiorentini Alessandro,Chiarucci Martina,Menotti Diego,Poloni Antonella,Discepoli Giancarlo,Leoni Pietro,Olivieri Attilio

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-020-01310-4.pdf

Reference56 articles.

1. Farag SS, Archer KJ, Mrozek K, et al. Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from cancer and leukemia group B 8461. Cancer and Leukemia Group B 8461. Blood. 2006;108:63–73.

2. Fröhling S, Schlenk RF, Kayser S, et al. Cytogenetics and age are the major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from the AMLSG trial AML HD98-B. Blood. 2006;108:3280–8.

3. Balducci L. Aging, frailty, and chemotherapy. Cancer Control. 2007;14:7–12.

4. Klepin HD, Balducci L. Acute myelogenous leukemia in older adults. Oncologist. 2009;14:222–32.

5. Godwin JE, Smith SE. Acute myeloid leukemia in the older patient. Crit Rev Oncol Hematol. 2003;48:S17–26.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking down frailty: Assessing vulnerability in acute myeloid leukemia;Blood Reviews;2024-07

2. Geriatric evaluation methods in oncology and their use in clinical studies: A systematic literature review;Journal of Geriatric Oncology;2023-12

3. Geriatric Assessment in Acute Myeloid Leukemia;Acta Haematologica;2023-11-30